GlaxoSmithKline (GSK) Granted New Trial Against Abbott Laboratories (ABT) Over Gay Juror Issue: U.S. Court  
1/22/2014 7:17:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday. GSK had won a jury verdict for about $3.5 million against Abbott over the pricing of HIV medications. At the conclusion of the four-week trial, the jury returned with a mixed verdict.

Help employers find you! Check out all the jobs and post your resume.